Thumbs Down for Genetic Test for Opioid Use Disorder, FDA Advisors Say

Posted on October 21, 2022 by Pharmaciststeve

Thumbs Down for Genetic Test for Opioid Use Disorder, FDA Advisors Say False positives, false negatives remain a concern https://www.medpagetoday.com/painmanagement/opioids/101359 An FDA advisory committee on Thursday voted strongly against AvertD, a prescription genetic risk assessment tool for opioid use disorder (OUD). In an 11-2 decision, the Clinical Chemistry and Clinical Toxicology Devices Advisory Committee said […]

Filed under: General Problems | 1 Comment »

Dr. Forest Tennant: Intractable Pain Syndrome | Episode 1

Posted on October 21, 2022 by Pharmaciststeve

https://youtu.be/RFazRe7TMAk

Filed under: General Problems | 1 Comment »

Florida Gov. Ron DeSantis says there will be no children’s COVID vaccine mandate

Posted on October 20, 2022 by Pharmaciststeve

We intentionally avoided the first mRNA vaccines and got the J&J/Jansen original vaccine and booster.  This most recent booster they are PUSHING is abt 50% of the original COVID-19 vaccine and other parts are suppose to be effective on the COVID-19 variations of BA.4 & BA.5 and the clinical trial consisted on it being test […]

Filed under: General Problems | 1 Comment »

Finally – An Honest Portrayal Of Opioid Overdose Deaths

Posted on October 20, 2022 by Pharmaciststeve

Notice in SECOND GRAPH – post 2016 CDC opiate dosing guidelines OD’s from illegal drugs ( Illegal Fentanyl, Cocaine, Heroin, Meth & other stimulants ) where HIGHER in 2021 Illegal fentanyl significantly so  … whereas, Rx opiates remained fairly CONSTANT. Since both pharma opiate products and prescribed opiate Rxs were declining…  does this suggest that […]

Filed under: General Problems | 1 Comment »

Genetic Testing for Opioid Use Disorder Heads to FDA Advisors

Posted on October 19, 2022 by Pharmaciststeve

Genetic Testing for Opioid Use Disorder Heads to FDA Advisors https://www.medpagetoday.com/painmanagement/opioids/101314 To date, no FDA-cleared or approved devices are indicated for identifying genetic risk of OUD On Thursday, members of the FDA’s Clinical Chemistry and Clinical Toxicology Devices Advisory Committee will meet to discuss AvertD, a prescription genetic risk assessment tool for opioid use disorder […]

Filed under: General Problems | 3 Comments »

Congressman Escalates War With PBMs – one of only 2 Pharmacist in Congress/House

Posted on October 18, 2022 by Pharmaciststeve

Congressman Escalates War With PBMs – one of only 2 Pharmacist in Congress/House They are hurting healthcare affordability and quality, says Rep. Buddy Carter https://www.medpagetoday.com/pharmacy/pharmacy/101124 SAVANNAH, Ga. — Representative Buddy Carter, BSPharm (R-Ga.), a pharmacist and former pharmacy owner, on Friday escalated his longstanding battle against pharmacy benefit managers (PBMs), releasing a report critical of […]

Filed under: General Problems | Leave a Comment »

Pharmacy benefit managers inflate drug prices and decrease competition while consumers pay the price. Does the FTC have the medicine to fix it?

Posted on October 18, 2022 by Pharmaciststeve

Pharmacy benefit managers inflate drug prices and decrease competition while consumers pay the price. Does the FTC have the medicine to fix it? Pharmacy benefit managers inflate drug prices and decrease competition while consumers pay the price. Does the FTC have the medicine to fix it? Many have never heard of a pharmacy benefit manager, […]

Filed under: General Problems | Leave a Comment »

Pres Biden has costs Medicare folks requiring insulin abt $900 extra on the cost of their insulin over TWO YEARS

Posted on October 17, 2022 by Pharmaciststeve

back in June 2020   Trump slashes cost of insulin for Medicare enrollees to $35 a month This plan would have limited the cost of insulin to Medicare folks to $35/month, starting in Jan 2021 Yes, Biden stopped a Trump order to lower insulin costs, but it would not have helped most diabetics President Biden took […]

Filed under: General Problems | Leave a Comment »

CDC 2022 Opioid Prescribing Guideline: Tapering – waiting for the other shoe to fall ?

Posted on October 16, 2022 by Pharmaciststeve

CDC 2022 Opioid Prescribing Guideline: Tapering https://www.practicalpainmanagement.com/resources/clinical-practice-guidelines/cdc-2022-opioid-prescribing-guideline-tapering Guideline Analysis: A look at the updated recommendations regarding the opioid tapering process and MME cutoffs. In this analysis, we break down the various aspects of the proposed revisions to the CDC Guideline on Opioid Prescribing for Chronic Pain to help clinicians, patients, and caretakers alike understand their […]

Filed under: General Problems | 3 Comments »

Stable, Long-term Opioid Therapy Safer Than Tapering?

Posted on October 16, 2022 by Pharmaciststeve

Stable, Long-term Opioid Therapy Safer Than Tapering? https://flashnews11.com/health/medicine/stable-long-term-opioid-therapy-safer-than-tapering/ Discontinuing secure, long-term opioid remedy is probably not obligatory for sufferers who present no indicators of misuse ― and it may even be safer than tapering or abrupt discontinuation, new analysis suggests. Investigators analyzed knowledge for nearly 200,000 sufferers who didn’t have indicators of opioid use dysfunction […]

Filed under: General Problems | 1 Comment »

« Previous Page — Next Page »